Circulating microRNA as biomarkers for young dyslipidemia men

S. Norizam, Norfilza Mohd Mokhtar, A. Azmir, M. M N Nor Anita, Zaiton Zakaria

Research output: Contribution to journalArticle

Abstract

Introduction: Cardiovascular diseases (CVD) are the major cause of morbidity and mortality in Malaysia, and dyslipidemia is a known contributing factor to the development of CVD. MicroRNAs (miRNAs) have been identified as potent post-transcriptional regulators of lipid metabolism, making it an important area of research to be explored in lipid disorders. Until today, no published data was reported on circulating miRNA among young men with dyslipidemia. Objective: To determine the differentially expressed miRNA between with dyslipidemia and nondyslipidemia in young men. Methods: Fourteen young males (32 ± 0.45 years) were recruited at UKMMC after obtaining written consent and were divided into dyslipidemia and non-dyslipidemia. Mean values for TC and LDL were significantly higher in dyslipidemia men compared to non-dyslipidemia (4.20 ± 0.8 mg/dl vs. 3.24 ± 0.33 mg/dl and 5.9 ± 0.67 mg/dl vs. 4.9 ± 0.31 mg/dl) (p<0.05), respectively. TG and HDL levels were not significant between both groups. Ten ml of blood was collected for total RNA extraction which then subjected to quantitative PCR using miRCURY LNA™ Universal RT microRNA PCR Serum/Plasma Focus Panel. All data was analysed using GenEx software (reference gene: miR-423-5p) and SPSS v.16 with p<0.05 was considered significant. Results & Discussion: Our results revealed six miRNAs were significantly upregulated and two were downregulated in dyslipidemia men compared to non-dyslipidemia (p<0.05). miR-144 is the most significant upregulated miRNA. This miRNA plays an important role in lipid metabolism as it targeted Liver X Receptor (LXR), an established key modulators of lipid metabolism. Eventually, it led to accumulation of cholesterol and attenuated cholesterol efflux by suppressing ABCA1 expression. ABCA1 is known to facilitate the efflux of cholesterol and phospholipids to lipid-poor lipoproteins. Conclusion: The study has successfully discovered a list of miRNA in circulating blood of young men with dyslipidemia. Further validation of these candidate miRNA is required before they are used as biomarkers for the current health problem in our community.

Original languageEnglish
Pages (from-to)235
Number of pages1
JournalAsian Pacific Journal of Tropical Disease
Volume4
Issue number3
DOIs
Publication statusPublished - Jun 2014

Fingerprint

Dyslipidemias
MicroRNAs
Biomarkers
Lipid Metabolism
Cholesterol
Cardiovascular Diseases
Lipids
Polymerase Chain Reaction
Malaysia
Lipoproteins
Phospholipids
Down-Regulation
Software
RNA
Morbidity
Mortality
Health
Serum
Research

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this

Circulating microRNA as biomarkers for young dyslipidemia men. / Norizam, S.; Mohd Mokhtar, Norfilza; Azmir, A.; Nor Anita, M. M N; Zakaria, Zaiton.

In: Asian Pacific Journal of Tropical Disease, Vol. 4, No. 3, 06.2014, p. 235.

Research output: Contribution to journalArticle

Norizam, S. ; Mohd Mokhtar, Norfilza ; Azmir, A. ; Nor Anita, M. M N ; Zakaria, Zaiton. / Circulating microRNA as biomarkers for young dyslipidemia men. In: Asian Pacific Journal of Tropical Disease. 2014 ; Vol. 4, No. 3. pp. 235.
@article{cca0af18b4d1495d8b245940233cae6f,
title = "Circulating microRNA as biomarkers for young dyslipidemia men",
abstract = "Introduction: Cardiovascular diseases (CVD) are the major cause of morbidity and mortality in Malaysia, and dyslipidemia is a known contributing factor to the development of CVD. MicroRNAs (miRNAs) have been identified as potent post-transcriptional regulators of lipid metabolism, making it an important area of research to be explored in lipid disorders. Until today, no published data was reported on circulating miRNA among young men with dyslipidemia. Objective: To determine the differentially expressed miRNA between with dyslipidemia and nondyslipidemia in young men. Methods: Fourteen young males (32 ± 0.45 years) were recruited at UKMMC after obtaining written consent and were divided into dyslipidemia and non-dyslipidemia. Mean values for TC and LDL were significantly higher in dyslipidemia men compared to non-dyslipidemia (4.20 ± 0.8 mg/dl vs. 3.24 ± 0.33 mg/dl and 5.9 ± 0.67 mg/dl vs. 4.9 ± 0.31 mg/dl) (p<0.05), respectively. TG and HDL levels were not significant between both groups. Ten ml of blood was collected for total RNA extraction which then subjected to quantitative PCR using miRCURY LNA™ Universal RT microRNA PCR Serum/Plasma Focus Panel. All data was analysed using GenEx software (reference gene: miR-423-5p) and SPSS v.16 with p<0.05 was considered significant. Results & Discussion: Our results revealed six miRNAs were significantly upregulated and two were downregulated in dyslipidemia men compared to non-dyslipidemia (p<0.05). miR-144 is the most significant upregulated miRNA. This miRNA plays an important role in lipid metabolism as it targeted Liver X Receptor (LXR), an established key modulators of lipid metabolism. Eventually, it led to accumulation of cholesterol and attenuated cholesterol efflux by suppressing ABCA1 expression. ABCA1 is known to facilitate the efflux of cholesterol and phospholipids to lipid-poor lipoproteins. Conclusion: The study has successfully discovered a list of miRNA in circulating blood of young men with dyslipidemia. Further validation of these candidate miRNA is required before they are used as biomarkers for the current health problem in our community.",
author = "S. Norizam and {Mohd Mokhtar}, Norfilza and A. Azmir and {Nor Anita}, {M. M N} and Zaiton Zakaria",
year = "2014",
month = "6",
doi = "10.1016/S2222-1808(14)60535-1",
language = "English",
volume = "4",
pages = "235",
journal = "Asian Pacific Journal of Tropical Disease",
issn = "2222-1808",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Circulating microRNA as biomarkers for young dyslipidemia men

AU - Norizam, S.

AU - Mohd Mokhtar, Norfilza

AU - Azmir, A.

AU - Nor Anita, M. M N

AU - Zakaria, Zaiton

PY - 2014/6

Y1 - 2014/6

N2 - Introduction: Cardiovascular diseases (CVD) are the major cause of morbidity and mortality in Malaysia, and dyslipidemia is a known contributing factor to the development of CVD. MicroRNAs (miRNAs) have been identified as potent post-transcriptional regulators of lipid metabolism, making it an important area of research to be explored in lipid disorders. Until today, no published data was reported on circulating miRNA among young men with dyslipidemia. Objective: To determine the differentially expressed miRNA between with dyslipidemia and nondyslipidemia in young men. Methods: Fourteen young males (32 ± 0.45 years) were recruited at UKMMC after obtaining written consent and were divided into dyslipidemia and non-dyslipidemia. Mean values for TC and LDL were significantly higher in dyslipidemia men compared to non-dyslipidemia (4.20 ± 0.8 mg/dl vs. 3.24 ± 0.33 mg/dl and 5.9 ± 0.67 mg/dl vs. 4.9 ± 0.31 mg/dl) (p<0.05), respectively. TG and HDL levels were not significant between both groups. Ten ml of blood was collected for total RNA extraction which then subjected to quantitative PCR using miRCURY LNA™ Universal RT microRNA PCR Serum/Plasma Focus Panel. All data was analysed using GenEx software (reference gene: miR-423-5p) and SPSS v.16 with p<0.05 was considered significant. Results & Discussion: Our results revealed six miRNAs were significantly upregulated and two were downregulated in dyslipidemia men compared to non-dyslipidemia (p<0.05). miR-144 is the most significant upregulated miRNA. This miRNA plays an important role in lipid metabolism as it targeted Liver X Receptor (LXR), an established key modulators of lipid metabolism. Eventually, it led to accumulation of cholesterol and attenuated cholesterol efflux by suppressing ABCA1 expression. ABCA1 is known to facilitate the efflux of cholesterol and phospholipids to lipid-poor lipoproteins. Conclusion: The study has successfully discovered a list of miRNA in circulating blood of young men with dyslipidemia. Further validation of these candidate miRNA is required before they are used as biomarkers for the current health problem in our community.

AB - Introduction: Cardiovascular diseases (CVD) are the major cause of morbidity and mortality in Malaysia, and dyslipidemia is a known contributing factor to the development of CVD. MicroRNAs (miRNAs) have been identified as potent post-transcriptional regulators of lipid metabolism, making it an important area of research to be explored in lipid disorders. Until today, no published data was reported on circulating miRNA among young men with dyslipidemia. Objective: To determine the differentially expressed miRNA between with dyslipidemia and nondyslipidemia in young men. Methods: Fourteen young males (32 ± 0.45 years) were recruited at UKMMC after obtaining written consent and were divided into dyslipidemia and non-dyslipidemia. Mean values for TC and LDL were significantly higher in dyslipidemia men compared to non-dyslipidemia (4.20 ± 0.8 mg/dl vs. 3.24 ± 0.33 mg/dl and 5.9 ± 0.67 mg/dl vs. 4.9 ± 0.31 mg/dl) (p<0.05), respectively. TG and HDL levels were not significant between both groups. Ten ml of blood was collected for total RNA extraction which then subjected to quantitative PCR using miRCURY LNA™ Universal RT microRNA PCR Serum/Plasma Focus Panel. All data was analysed using GenEx software (reference gene: miR-423-5p) and SPSS v.16 with p<0.05 was considered significant. Results & Discussion: Our results revealed six miRNAs were significantly upregulated and two were downregulated in dyslipidemia men compared to non-dyslipidemia (p<0.05). miR-144 is the most significant upregulated miRNA. This miRNA plays an important role in lipid metabolism as it targeted Liver X Receptor (LXR), an established key modulators of lipid metabolism. Eventually, it led to accumulation of cholesterol and attenuated cholesterol efflux by suppressing ABCA1 expression. ABCA1 is known to facilitate the efflux of cholesterol and phospholipids to lipid-poor lipoproteins. Conclusion: The study has successfully discovered a list of miRNA in circulating blood of young men with dyslipidemia. Further validation of these candidate miRNA is required before they are used as biomarkers for the current health problem in our community.

UR - http://www.scopus.com/inward/record.url?scp=84896737875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896737875&partnerID=8YFLogxK

U2 - 10.1016/S2222-1808(14)60535-1

DO - 10.1016/S2222-1808(14)60535-1

M3 - Article

AN - SCOPUS:84896737875

VL - 4

SP - 235

JO - Asian Pacific Journal of Tropical Disease

JF - Asian Pacific Journal of Tropical Disease

SN - 2222-1808

IS - 3

ER -